Apex Biotechnology Corp. (1733) - Financial and Strategic SWOT Analysis Review

Date: August 18, 2015
Pages: 34
Price:
US$ 125.00
License [?]:
Publisher: GlobalData
Report type: Strategic Report
Delivery: E-mail Delivery (PDF)
ID: AC026A38C73EN
Leaflet:

Download PDF Leaflet

Apex Biotechnology Corp. (1733) - Financial and Strategic SWOT Analysis Review
Apex Biotechnology Corp. (1733) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weaknesses and the potential opportunities and threats. The profile helps you formulate strategies that augment your business by enabling you to understand your partners, customers and competitors better.

The profile contains critical company information including:
  • Business description – A detailed description of the company’s operations and business divisions.
  • Corporate strategy – Analyst’s summarization of the company’s business strategy.
  • SWOT Analysis – A detailed analysis of the company’s strengths, weakness, opportunities and threats.
  • Company history – Progression of key events associated with the company.
  • Major products and services – A list of major products, services and brands of the company.
  • Key competitors – A list of key competitors to the company.
  • Key employees – A list of the key executives of the company.
  • Executive biographies – A brief summary of the executives’ employment history.
  • Key operational heads – A list of personnel heading key departments/functions.
  • Important locations and subsidiaries – A list and contact details of key locations and subsidiaries of the company.
  • Key manufacturing facilities – A list of key manufacturing facilities of the company.
  • Detailed financial ratios for the past five years – The latest financial ratios derived from the annual financial statements published by the company with 5 years history.
  • Interim ratios for the last five interim periods – The latest financial ratios derived from the quarterly/semi-annual financial statements published by the company for 5 interims history.
Highlights

Apex Biotechnology Corp. (ApexBio) is a medical device company. It develops, manufactures and commercializes biosensor-based blood glucose monitoring system. Besides, the company also imports and exports related products, parts and components. ApexBio's product portfolio consists of blood glucose monitoring system, blood uric acid monitoring system, blood cholesterol monitoring system, blood hemoglobin monitoring system, blood lactic acid monitoring system, poc HbA1c testing system and vegetable/fruits residual pesticide quick detection kit. These products are certified by FDA, CE, PMDA in Japan, and SFDA in China. The company manufactures the products in ISO13485 certified and GMP approved manufacturing facilities. ApexBio is headquartered in Hsinchu, Taiwan.

Key benefits of buying this profile include:

You get detailed information about the company and its operations to identify potential customers and suppliers.
  • The profile analyzes the company’s business structure, operations, major products and services, prospects, locations and subsidiaries, key executives and their biographies and key competitors.
Understand and respond to your competitors’ business structure and strategies, and capitalize on their weaknesses. Stay up to date on the major developments affecting the company.
  • The company’s core strengths and weaknesses and areas of development or decline are analyzed and presented in the profile objectively. Recent developments in the company covered in the profile help you track important events.
Equip yourself with information that enables you to sharpen your strategies and transform your operations profitably.
  • Opportunities that the company can explore and exploit are sized up and its growth potential assessed in the profile. Competitive and/or technological threats are highlighted.
Scout for potential investments and acquisition targets, with detailed insight into the companies’ strategic, financial and operational performance.
  • Financial ratio presented for major public companies in the profile include the revenue trends, profitability, growth, margins and returns, liquidity and leverage, financial position and efficiency ratios.
Gain key insights into the company for academic or business research.
  • Key elements such as SWOT analysis, corporate strategy and financial ratios and charts are incorporated in the profile to assist your academic or business research needs.
Note: Some sections may be missing if data is unavailable for the company
SECTION 1 - ABOUT THE COMPANY

Apex Biotechnology Corp. - Key Facts
Apex Biotechnology Corp. - Key Employees
Apex Biotechnology Corp. - Key Employee Biographies
Apex Biotechnology Corp. - Major Products and Services
Apex Biotechnology Corp. - History
Apex Biotechnology Corp. - Company Statement
Apex Biotechnology Corp. - Locations And Subsidiaries
Head Office

SECTION 2 – COMPANY ANALYSIS

Apex Biotechnology Corp. - Business Description
Apex Biotechnology Corp. - Corporate Strategy
Apex Biotechnology Corp. - SWOT Analysis
SWOT Analysis - Overview
Apex Biotechnology Corp. - Strengths
Strength - Research and Development
Strength - Commitment to Quality
Apex Biotechnology Corp. - Weaknesses
Weakness - Declining Profitability
Weakness - Increasing Trade Receivables
Apex Biotechnology Corp. - Opportunities
Opportunity - Growing IVD Market
Opportunity - Growing Diabetes Care Devices Market
Opportunity - Market Growth in Emerging Economies
Apex Biotechnology Corp. - Threats
Threat - Stringent Government Regulations
Threat - Rapid Technological Changes
Threat - Cost Containment Pressures
Apex Biotechnology Corp. - Key Competitors

SECTION 3 – COMPANY FINANCIAL RATIOS

Financial Ratios - Capital Market Ratios
Financial Ratios - Annual Ratios
Performance Chart
Financial Performance
Financial Ratios - Interim Ratios
Financial Ratios - Ratio Charts

SECTION 4 – COMPANY’S LIFESCIENCES FINANCIAL DEALS AND ALLIANCES

Apex Biotechnology Corp., Medical Equipment, Deals By Year, 2009 to YTD 2015
Apex Biotechnology Corp., Medical Equipment, Deals By Type, 2009 to YTD 2015
Apex Biotechnology Corp., Recent Deals Summary

SECTION 5 – APPENDIX

Methodology
Ratio Definitions
About GlobalData
Contact Us
Disclaimer

LIST OF TABLES

Apex Biotechnology Corp., Key Facts
Apex Biotechnology Corp., Key Employees
Apex Biotechnology Corp., Key Employee Biographies
Apex Biotechnology Corp., Major Products and Services
Apex Biotechnology Corp., History
Apex Biotechnology Corp., Key Competitors
Apex Biotechnology Corp., Ratios based on current share price
Apex Biotechnology Corp., Annual Ratios
Apex Biotechnology Corp., Interim Ratios
Apex Biotechnology Corp., Medical Equipment, Deals By Year, 2009 to YTD 2015
Apex Biotechnology Corp., Medical Equipment, Deals By Type, 2009 to YTD 2015
Apex Biotechnology Corp., Recent Deals Summary
Currency Codes
Capital Market Ratios
Equity Ratios
Profitability Ratios
Cost Ratios
Liquidity Ratios
Leverage Ratios
Efficiency Ratios

LIST OF FIGURES

Apex Biotechnology Corp., Performance Chart (2010 - 2014)
Apex Biotechnology Corp., Ratio Charts
Apex Biotechnology Corp., Medical Equipment, Deals By Year, 2009 to YTD 2015
Apex Biotechnology Corp., Medical Equipment, Deals by Type, 2009 to YTD 2015
Skip to top


Ask Your Question

Apex Biotechnology Corp. (1733) - Financial and Strategic SWOT Analysis Review
Company name*:
Contact person*:
Phone/fax*:
Email*:
Request invoice
Your enquiry:
Please click on a Check Box below to confirm you are not a robot: